Algorithms trained on ten million ECGs are now outperforming cardiologists in early detection. But who owns the data — and who bears the risk?
The gene-editing tool once confined to laboratories is now in its first human trials.
Alzheimer's therapeutics are advancing faster than the ethics can keep pace.
The gut-brain axis is reshaping how we understand mood and cognition.
A decade lost in diagnosis for one of medicine's most common conditions.
The first regulated trials of autonomous diagnostic systems are underway.
As temperatures rise, tropical disease is migrating into new territory.
Join 240,000 readers — clinicians, policymakers, researchers, and curious minds — who start their week with the most important healthcare stories from around the world.